Logo image of ABI.BR

ANHEUSER-BUSCH INBEV SA/NV (ABI.BR) Stock Fundamental Analysis

EBR:ABI - Euronext Brussels - BE0974293251 - Common Stock - Currency: EUR

62.09  +0.13 (+0.21%)

Fundamental Rating

4

ABI gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 25 industry peers in the Beverages industry. There are concerns on the financial health of ABI while its profitability can be described as average. ABI has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year ABI was profitable.
ABI had a positive operating cash flow in the past year.
ABI had positive earnings in each of the past 5 years.
Each year in the past 5 years ABI had a positive operating cash flow.
ABI.BR Yearly Net Income VS EBIT VS OCF VS FCFABI.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

1.2 Ratios

ABI has a Return On Assets (2.83%) which is comparable to the rest of the industry.
Looking at the Return On Equity, with a value of 7.48%, ABI is in line with its industry, outperforming 56.00% of the companies in the same industry.
ABI has a Return On Invested Capital of 6.49%. This is in the lower half of the industry: ABI underperforms 60.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ABI is in line with the industry average of 7.98%.
The last Return On Invested Capital (6.49%) for ABI is above the 3 year average (6.05%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 2.83%
ROE 7.48%
ROIC 6.49%
ROA(3y)2.69%
ROA(5y)2.17%
ROE(3y)7.38%
ROE(5y)6.2%
ROIC(3y)6.05%
ROIC(5y)5.66%
ABI.BR Yearly ROA, ROE, ROICABI.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

Looking at the Profit Margin, with a value of 9.80%, ABI is in line with its industry, outperforming 56.00% of the companies in the same industry.
In the last couple of years the Profit Margin of ABI has declined.
Looking at the Operating Margin, with a value of 25.87%, ABI is in the better half of the industry, outperforming 76.00% of the companies in the same industry.
In the last couple of years the Operating Margin of ABI has declined.
ABI's Gross Margin of 55.25% is fine compared to the rest of the industry. ABI outperforms 64.00% of its industry peers.
ABI's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 25.87%
PM (TTM) 9.8%
GM 55.25%
OM growth 3Y-0.42%
OM growth 5Y-3.7%
PM growth 3Y4.44%
PM growth 5Y-10.98%
GM growth 3Y-1.3%
GM growth 5Y-1.99%
ABI.BR Yearly Profit, Operating, Gross MarginsABI.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ABI is creating some value.
The number of shares outstanding for ABI has been reduced compared to 1 year ago.
ABI has more shares outstanding than it did 5 years ago.
The debt/assets ratio for ABI has been reduced compared to a year ago.
ABI.BR Yearly Shares OutstandingABI.BR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B
ABI.BR Yearly Total Debt VS Total AssetsABI.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B 200B 250B

2.2 Solvency

ABI has an Altman-Z score of 1.81. This is not the best score and indicates that ABI is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 1.81, ABI is in line with its industry, outperforming 44.00% of the companies in the same industry.
ABI has a debt to FCF ratio of 6.45. This is a slightly negative value and a sign of low solvency as ABI would need 6.45 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 6.45, ABI is in the better half of the industry, outperforming 72.00% of the companies in the same industry.
ABI has a Debt/Equity ratio of 0.90. This is a neutral value indicating ABI is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.90, ABI is in line with its industry, outperforming 52.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.9
Debt/FCF 6.45
Altman-Z 1.81
ROIC/WACC1.06
WACC6.15%
ABI.BR Yearly LT Debt VS Equity VS FCFABI.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

2.3 Liquidity

A Current Ratio of 0.70 indicates that ABI may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.70, ABI is doing worse than 84.00% of the companies in the same industry.
A Quick Ratio of 0.54 indicates that ABI may have some problems paying its short term obligations.
ABI has a worse Quick ratio (0.54) than 60.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.7
Quick Ratio 0.54
ABI.BR Yearly Current Assets VS Current LiabilitesABI.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

4

3. Growth

3.1 Past

ABI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 13.33%, which is quite good.
Measured over the past years, ABI shows a decrease in Earnings Per Share. The EPS has been decreasing by -1.83% on average per year.
Looking at the last year, ABI shows a decrease in Revenue. The Revenue has decreased by -1.45% in the last year.
Measured over the past years, ABI shows a small growth in Revenue. The Revenue has been growing by 2.69% on average per year.
EPS 1Y (TTM)13.33%
EPS 3Y4.79%
EPS 5Y-1.83%
EPS Q2Q%8%
Revenue 1Y (TTM)-1.45%
Revenue growth 3Y3.25%
Revenue growth 5Y2.69%
Sales Q2Q%-6.32%

3.2 Future

The Earnings Per Share is expected to grow by 11.42% on average over the next years. This is quite good.
The Revenue is expected to grow by 4.35% on average over the next years.
EPS Next Y4.12%
EPS Next 2Y8.45%
EPS Next 3Y12.23%
EPS Next 5Y11.42%
Revenue Next Year1.78%
Revenue Next 2Y3.14%
Revenue Next 3Y3.48%
Revenue Next 5Y4.35%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ABI.BR Yearly Revenue VS EstimatesABI.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 20B 40B 60B 80B
ABI.BR Yearly EPS VS EstimatesABI.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6

4

4. Valuation

4.1 Price/Earnings Ratio

ABI is valuated rather expensively with a Price/Earnings ratio of 20.03.
ABI's Price/Earnings is on the same level as the industry average.
The average S&P500 Price/Earnings ratio is at 26.32. ABI is valued slightly cheaper when compared to this.
With a Price/Forward Earnings ratio of 17.31, ABI is valued on the expensive side.
ABI's Price/Forward Earnings is on the same level as the industry average.
ABI's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.13.
Industry RankSector Rank
PE 20.03
Fwd PE 17.31
ABI.BR Price Earnings VS Forward Price EarningsABI.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ABI is valued a bit cheaper than 64.00% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ABI indicates a somewhat cheap valuation: ABI is cheaper than 76.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 12.39
EV/EBITDA 9.23
ABI.BR Per share dataABI.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ABI does not grow enough to justify the current Price/Earnings ratio.
ABI's earnings are expected to grow with 12.23% in the coming years. This may justify a more expensive valuation.
PEG (NY)4.86
PEG (5Y)N/A
EPS Next 2Y8.45%
EPS Next 3Y12.23%

2

5. Dividend

5.1 Amount

ABI has a Yearly Dividend Yield of 1.13%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 2.89, ABI is paying slightly less dividend.
With a Dividend Yield of 1.13, ABI pays less dividend than the S&P500 average, which is at 2.40.
Industry RankSector Rank
Dividend Yield 1.13%

5.2 History

The dividend of ABI decreases each year by -12.03%.
Dividend Growth(5Y)-12.03%
Div Incr Years3
Div Non Decr Years4
ABI.BR Yearly Dividends per shareABI.BR Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

45.64% of the earnings are spent on dividend by ABI. This is a bit on the high side, but may be sustainable.
DP45.64%
EPS Next 2Y8.45%
EPS Next 3Y12.23%
ABI.BR Yearly Income VS Free CF VS DividendABI.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B
ABI.BR Dividend Payout.ABI.BR Dividend Payout, showing the Payout Ratio.ABI.BR Dividend Payout.PayoutRetained Earnings

ANHEUSER-BUSCH INBEV SA/NV

EBR:ABI (6/16/2025, 4:31:17 PM)

62.09

+0.13 (+0.21%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)05-08 2025-05-08/bmo
Earnings (Next)07-31 2025-07-31/bmo
Inst Owners19.76%
Inst Owner ChangeN/A
Ins Owners0.01%
Ins Owner ChangeN/A
Market Cap120.42B
Analysts83.75
Price Target73.37 (18.17%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.13%
Yearly Dividend1.17
Dividend Growth(5Y)-12.03%
DP45.64%
Div Incr Years3
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)13.01%
Min EPS beat(2)5.76%
Max EPS beat(2)20.27%
EPS beat(4)4
Avg EPS beat(4)10.29%
Min EPS beat(4)4.3%
Max EPS beat(4)20.27%
EPS beat(8)8
Avg EPS beat(8)6.77%
EPS beat(12)10
Avg EPS beat(12)7.21%
EPS beat(16)13
Avg EPS beat(16)7.45%
Revenue beat(2)1
Avg Revenue beat(2)0.19%
Min Revenue beat(2)-4.2%
Max Revenue beat(2)4.57%
Revenue beat(4)2
Avg Revenue beat(4)-0.03%
Min Revenue beat(4)-4.2%
Max Revenue beat(4)4.57%
Revenue beat(8)2
Avg Revenue beat(8)-1.53%
Revenue beat(12)4
Avg Revenue beat(12)-1.48%
Revenue beat(16)7
Avg Revenue beat(16)-0.4%
PT rev (1m)2.86%
PT rev (3m)3.52%
EPS NQ rev (1m)0.61%
EPS NQ rev (3m)-1.48%
EPS NY rev (1m)0%
EPS NY rev (3m)2.86%
Revenue NQ rev (1m)-0.01%
Revenue NQ rev (3m)-0.73%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.33%
Valuation
Industry RankSector Rank
PE 20.03
Fwd PE 17.31
P/S 2.32
P/FCF 12.39
P/OCF 9.21
P/B 1.77
P/tB N/A
EV/EBITDA 9.23
EPS(TTM)3.1
EY4.99%
EPS(NY)3.59
Fwd EY5.78%
FCF(TTM)5.01
FCFY8.07%
OCF(TTM)6.74
OCFY10.86%
SpS26.77
BVpS35.04
TBVpS-32.37
PEG (NY)4.86
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.83%
ROE 7.48%
ROCE 8.91%
ROIC 6.49%
ROICexc 6.95%
ROICexgc 96.58%
OM 25.87%
PM (TTM) 9.8%
GM 55.25%
FCFM 18.73%
ROA(3y)2.69%
ROA(5y)2.17%
ROE(3y)7.38%
ROE(5y)6.2%
ROIC(3y)6.05%
ROIC(5y)5.66%
ROICexc(3y)6.43%
ROICexc(5y)6.06%
ROICexgc(3y)81%
ROICexgc(5y)72.75%
ROCE(3y)8.3%
ROCE(5y)7.79%
ROICexcg growth 3Y11.31%
ROICexcg growth 5Y15.72%
ROICexc growth 3Y4.65%
ROICexc growth 5Y2.73%
OM growth 3Y-0.42%
OM growth 5Y-3.7%
PM growth 3Y4.44%
PM growth 5Y-10.98%
GM growth 3Y-1.3%
GM growth 5Y-1.99%
F-Score8
Asset Turnover0.29
Health
Industry RankSector Rank
Debt/Equity 0.9
Debt/FCF 6.45
Debt/EBITDA 3.37
Cap/Depr 69.68%
Cap/Sales 6.46%
Interest Coverage 4.24
Cash Conversion 71.67%
Profit Quality 191.15%
Current Ratio 0.7
Quick Ratio 0.54
Altman-Z 1.81
F-Score8
WACC6.15%
ROIC/WACC1.06
Cap/Depr(3y)85.67%
Cap/Depr(5y)89.39%
Cap/Sales(3y)7.73%
Cap/Sales(5y)8.33%
Profit Quality(3y)163.01%
Profit Quality(5y)238.24%
High Growth Momentum
Growth
EPS 1Y (TTM)13.33%
EPS 3Y4.79%
EPS 5Y-1.83%
EPS Q2Q%8%
EPS Next Y4.12%
EPS Next 2Y8.45%
EPS Next 3Y12.23%
EPS Next 5Y11.42%
Revenue 1Y (TTM)-1.45%
Revenue growth 3Y3.25%
Revenue growth 5Y2.69%
Sales Q2Q%-6.32%
Revenue Next Year1.78%
Revenue Next 2Y3.14%
Revenue Next 3Y3.48%
Revenue Next 5Y4.35%
EBIT growth 1Y5.98%
EBIT growth 3Y2.81%
EBIT growth 5Y-1.1%
EBIT Next Year40.75%
EBIT Next 3Y16.41%
EBIT Next 5Y12.43%
FCF growth 1Y29.73%
FCF growth 3Y6.91%
FCF growth 5Y4.78%
OCF growth 1Y13.49%
OCF growth 3Y0.57%
OCF growth 5Y1.41%